← brief for 2026-10-20 · Slowing decline

Safety outcomes of semaglutide by chronic kidney disease severity in the FLOW trial

Paper No results yet Not peer reviewed

Key takeaways

This article looks at the safety of semaglutide in people with kidney disease. It is a journal page, not a full study with results. It discusses a possible safety profile, but there are no clinical trial results to report yet.

Source

Paper · Kidney International · 2026-10-20
https://www.kidney-international.org/article/S0085-2538(26)00847-1/fulltext?rss=yes